TY - JOUR T1 - Predicting inpatient flow at a major hospital using interpretable analytics JF - medRxiv DO - 10.1101/2020.05.12.20098848 SP - 2020.05.12.20098848 AU - Dimitris Bertsimas AU - Jean Pauphilet AU - Jennifer Stevens AU - Manu Tandon Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/16/2020.05.12.20098848.abstract N2 - Problem definition Turn raw data from Electronic Health Records into accurate predictions on patient flows and inform daily decision-making at a major hospital.Practical Relevance In a hospital environment under increasing financial and operational stress, forecasts on patient demand patterns could help match capacity and demand and improve hospital operations.Methodology We use data from 63, 432 admissions at a large academic hospital (50.0% female, median age 64 years old, median length-of-stay 3.12 days). We construct an expertise-driven patient representation on top of their EHR data and apply a broad class of machine learning methods to predict several aspects of patient flows.Results With a unique patient representation, we estimate short-term discharges, identify long-stay patients, predict discharge destination and anticipate flows in and out of intensive care units with accuracy in the 80%+ range. More importantly, we implement this machine learning pipeline into the EHR system of the hospital and construct prediction-informed dashboards to support daily bed placement decisions.Managerial Implications Our study demonstrates that interpretable machine learning techniques combined with EHR data can be used to provide visibility on patient flows. Our approach provides an alternative to deep learning techniques which is equally accurate, interpretable, frugal in data and computational power, and production-ready.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received to conduct the studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional review board at BIDMC approved the study with waiver of informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is not available ER -